Chuck Ence - 16 Dec 2022 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
CA and Compliance Officer
Signature
/s/ Chuck Ence
Issuer symbol
RLMD
Transactions as of
16 Dec 2022
Net transactions value
$0
Form type
4
Filing time
20 Dec 2022, 18:30:30 UTC
Previous filing
21 Dec 2021
Next filing
30 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Other -200,000 -100% 0 16 Dec 2022 Common stock 200,000 $19.03 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the termination of milestone-based stock options granted to the reporting person on May 25, 2022, that were eligible to vest based on achievement of certain corporate objectives by the Issuer. Upon grant, the target vesting amount was reported in Table II of Form 4. On December 16, 2022, the Board of Directors determined that such milestone objectives were not achieved by the Issuer and that all 200,000 options would be terminated.
F2 Not applicable.
F3 Original expiration date.